Skip to main content
. 2020 Dec 16;13:12867–12880. doi: 10.2147/OTT.S279997

Figure 2.

Figure 2

Low ApoA1 level is significantly associated with poorer patient survival. Low ApoA1 level is significantly associated with poorer overall survival (A) and disease-free survival (B), in a test cohort of 242 HCC patients. Low ApoA1 level is significantly associated with poorer overall survival (C) and recurrence-free survival (D), in a validation cohort of 229 HCC patients.